Point-of-Care Testing refers to diagnostic or monitoring tests performed close to the location where a patient receives care rather than requiring the specimen to be transported to a central laboratory before the result is available. It is sometimes described as near-patient testing. Examples include blood-glucose meters, pregnancy tests, some infectious-disease tests, blood-gas analysers and certain coagulation measurements. The defining characteristic is proximity to the patient and rapid availability of results, rather than a particular analytical technology. Point-of-care systems can be used in hospitals, primary care, pharmacies, ambulances, community settings and, for some tests, homes.
The main purpose of Point-of-Care Testing is to shorten the interval between specimen collection and actionable information. Rapid results can support immediate clinical decisions, such as determining whether a patient requires escalation, adjusting treatment or obtaining further diagnostic investigations. In emergency and critical-care environments, rapid blood-gas and electrolyte measurements can be particularly useful because physiological changes may require immediate response. Home glucose monitoring provides another example in which repeated measurements can directly inform day-to-day management. The value of rapid testing depends on whether receiving the result sooner changes an appropriate clinical decision.
Point-of-Care Testing devices range from simple lateral-flow assays to sophisticated electronic analysers. Lateral-flow tests can detect antigens, antibodies or hormones through immunochemical reactions and are widely used for certain infections and pregnancy testing. Portable blood analysers can measure multiple biochemical parameters from small blood samples. Some systems use electrochemical sensors to quantify substances such as glucose, while molecular point-of-care platforms can amplify and detect pathogen nucleic acids. Each technology has different requirements for sample preparation, calibration, operator training and environmental conditions.
Accuracy and quality assurance are central challenges because Point-of-Care Testing may be performed outside conventional laboratory environments. Devices can be affected by temperature, humidity, calibration errors, inadequate sample volume, expired consumables, operator technique and incorrect storage. Quality-control procedures help identify unreliable instruments or reagents, while staff training reduces procedural errors. Results that are unexpected or inconsistent with the clinical picture may require confirmation using a laboratory method. Point-of-care does not mean automatically less accurate; it means that testing occurs closer to the patient and often under different operational conditions.
Point-of-Care Testing can improve access where conventional laboratories are distant or slow. It is particularly useful in remote locations, urgent-care environments and settings where rapid decisions are necessary. During outbreaks, rapid testing can potentially accelerate identification and isolation of people with certain infections, although performance varies substantially among individual tests and stages of disease. In resource-limited settings, appropriately selected point-of-care technologies can support diagnosis without requiring a full central laboratory infrastructure. Implementation still requires reliable supply chains, waste management, quality assurance and appropriate clinical interpretation.
The interpretation of Point-of-Care Testing results depends on test characteristics such as sensitivity, specificity, analytical range and detection threshold. A rapid test with lower sensitivity than a laboratory reference method may miss some cases, particularly when the amount of target material is low. Conversely, testing a low-risk population with a relatively uncommon disease can produce a substantial proportion of false-positive results even when specificity is high. Predictive values therefore depend on the population being tested and the reason for testing. A rapid result is useful only when its limitations are understood.
Point-of-Care Testing should be distinguished from self-testing. Self-testing is performed by an individual without a healthcare professional directly performing the test, whereas point-of-care testing can be performed by trained professionals outside a central laboratory. Some tests can be both point-of-care and self-tests depending on how they are used. Point-of-care systems also differ from conventional laboratory testing in workflow rather than necessarily in underlying scientific principle. Many use the same fundamental biochemical, immunological or molecular reactions but package them into portable instruments with simplified operation and rapid reporting.
The advantages of Point-of-Care Testing include speed, convenience, reduced specimen transport and potential expansion of diagnostic access. Limitations include variable analytical performance, operator dependence, consumable costs, connectivity requirements and the possibility that rapid availability encourages inappropriate testing or overinterpretation. Effective implementation therefore requires governance covering device selection, training, quality control, result recording and escalation procedures. Point-of-care testing is most clinically valuable when rapid information is integrated into a defined care pathway rather than treated as a substitute for all conventional laboratory investigation.
